Pediatric Frontlines
how-the-collagen-x-biomarker-could-change-the-future-of-scoliosis-care [https://support.doctorpodcasting.com/media/k2/items/cache/ae624a0f25ad46f4b6200212207f50dc_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/ae624a0f25ad46f4b6200212207f50dc_Generic.jpg Michelle Welborn, M.D., FAAOS, is the chief of spine surgery and president of the medical staff at Shriners Children’s Portland. Dr. Welborn’s research has shown that the collagen X biomarker in scoliosis patients is a key indicator of current growth and required bracing. Learn more about Michelle C. Welborn, MD [https://www.shrinerschildrens.org/en/our-care-providers/w/michelle-c-welborn-md-57718]
5 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Pediatric Frontlines!